Why is Sanofi India falling/rising?

As of 04-Sep, Sanofi India Ltd's stock price is currently at 5,117.00, reflecting a decrease of 16.45 or 0.32%. The stock has shown a trend reversal, falling after three consecutive days of gains. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has declined by 0.15%, and it has experienced a significant drop of 29.53% over the past year, underperforming the broader market, which has seen a decline of only 1.98% during the same period. Despite a rise in investor participation, with a 23.35% increase in delivery volume, the overall performance remains concerning due to poor long-term growth metrics, including a net sales decline of 8.57% annually over the last five years.
In the broader market context, while the Sensex has gained 0.80% over the past week, Sanofi India’s performance has lagged significantly, reflecting a broader trend of underperformance against market benchmarks. The company's high management efficiency and low debt-to-equity ratio are positive factors; however, these are overshadowed by declining profits and flat results in recent quarters. The stock is trading at a premium compared to its peers, which may deter potential investors amid its poor growth outlook and negative returns. Overall, the combination of weak financial performance and unfavorable market conditions contributes to the stock's downward movement.